| Ab | Antibody |
| ACVR1/ALK2 | Activin a receptor, type 1 |
| ADAM10 | A disintegrin and metalloproteinase domain-containing protein 10 |
| AKT | Protein kinase B |
| ATRX | Alpha-Thalassemia/Mental Retardation Syndrome, X-Linked |
| B7-H3 | CD276 (target of 8H9 antibody) |
| BET | Bromodomain and extra-terminal motif |
| BRD4 | Bromodomain-containing protein 4 |
| CAR-T | Chimeric antigen receptor T cell |
| CDK | Cyclin-dependent kinase |
| DMG | Diffuse midline glioma, H3K27M-mutant |
| DRD2 | Dopamine receptor D2 |
| EZH2 | Enhancer of zeste 2 |
| Flt3L | FMS-like tyrosine kinase 3 ligand |
| GD2 | Disialoganglioside GD2 |
| GEMM | Genetically engineered mouse model |
| HDAC | Histone deacetylase |
| IUE | In utero electroporation |
| JMJD3/KDM6B | Jumonji domain-containing protein D3/lysine-specific demethylase 6B |
| MHC | Major histocompatibility complex |
| mTOR | Mechanistic target of rapamycin |
| NAD+ | Nicotinamide adenine dinucleotide |
| NAMPT | Nicotinamide phosphoribosyltransferase |
| [s]NLGN3 | [Soluble] neuroligin 3 |
| NPC | Neural progenitor cell |
| OPC | Oligodendrocyte progenitor cell |
| PARP | Poly (ADP-ribose) polymerase |
| PD1/PDL1 | Programmed death 1/programmed death ligand 1 |
| PDGF-B | Platelet-derived growth factor subunit B |
| PDGFRA | Platelet-derived growth factor receptor A |
| PDX | Patient-derived xenograft |
| pHGG | Pediatric high-grade glioma |
| PI3K | Phosphatidylinositol 3-kinase |
| PIK3CA/PIK3R1 | PI3K catalytic/regulatory subunits |
| PPM1D | Protein Phosphatase, Mg2+/Mn2+ Dependent 1D |
| PRC2 | Polycomb repressive complex 2. |
| RCAS/t-va | Replication-competent avian sarcoma-leukosis virus long-terminal repeat with Splice acceptor/tumor virus A |
| SET | Su(var)3-9, Enhancer-of-Zeste and Trithorax |
| shRNA | Short hairpin RNA |
| SUZ12 | Suppressor of zeste-12 |
| TK | Thymidine kinase |